Your session is about to expire
← Back to Search
Topical Analgesic
Lidocaine5% v Lidocaine3.6%,Menthol1.25% for Arthritis
N/A
Waitlist Available
Research Sponsored by J.A.R. Laboratories
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 10
Awards & highlights
Study Summary
A comparison of transdermal patches for efficacy, side effects and quality of life for patients with back pain and arthritis. The three arms in the trial were; prescription strength lidocaine 5%, over the counter lidocaine 3.6%, menthol 1.25% and placebo.
Eligible Conditions
- Arthritis
- Back Pain
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day ten
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day ten
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Efficacy comparison of lidocaine 5% and lidocaine 3.6%, menthol 1.25% as measured by VAS numeric 0-10 pain scale
Secondary outcome measures
Efficacy comparison of placebo and lidocaine 3.6%, menthol 1.25% as measured by VAS numeric 0-10 pain scale
Lidocaine
Lidocaine
+1 moreTrial Design
2Treatment groups
Active Control
Placebo Group
Group I: Lidocaine5% v Lidocaine3.6%,Menthol1.25%Active Control2 Interventions
Daily patch Q12 followed by Q12 of no patch
Group II: Lidocaine 3.6%, menthol 1.25% v placeboPlacebo Group2 Interventions
Daily patch Q12 followed by Q12 of no patch
Find a Location
Who is running the clinical trial?
J.A.R. LaboratoriesLead Sponsor
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger